Company Number: 15113827

Analysis Date: 2025-07-19 12:46 UTC

1. Risk Rating: HIGH
   Justification: The company is newly incorporated (September 2023) with limited operating history and exhibits negative net current assets (£-551), indicating current liabilities exceed current assets. This points to liquidity risk and potential difficulties meeting short-term obligations. Shareholders’ funds are minimal (£563), reflecting a very small capital base.

2. Key Concerns:

• Liquidity Deficit: Negative working capital suggests potential cash flow problems to cover immediate debts.
• Limited Financial History: With just over one year of operation, there is insufficient data to assess sustainable profitability or operational stability.
• Concentration of Control: 100% ownership and director responsibility rest with a single individual, which may increase governance risk and reduce oversight.

3. Positive Indicators:

• Compliance: Company is up to date on statutory filings with no overdue accounts or confirmation statements, indicating good regulatory adherence so far.
• No Audit Required: The company qualifies for audit exemption under the small companies regime, reducing immediate financial reporting burdens.
• Clear Accounting Policies: The financial statements disclose accounting policies and demonstrate compliance with relevant accounting standards, which supports transparency.

4. Due Diligence Notes:

• Review cash flow statements and management projections to assess ability to improve liquidity and meet liabilities.
• Investigate the nature and timing of current liabilities to understand if these are short-term operational debts or related party balances.
• Evaluate the business plan and revenue generation model given the SIC code (other human health activities) to confirm sustainable operations.
• Consider the background and financial capacity of the sole director/shareholder to support the company through early-stage risks.
• Monitor future filings for signs of financial distress or changes in control structure.